Federal Register / Vol. 66, No. 109 / Wednesday, June 6, 2001 / Notices 30471

donor history questionnaire. On June

15, 2001, the following updates are

tentatively scheduled: Summaries of the

Office of Blood Research and Review,

Center for Biologics Evaluation and

Research (CBER), transmissible

spongiform encephalopathy (TSE) and

bovine spongiform encephalopathy

(BSE) action plans. In the morning, the

committee will hear an informational

presentation, and discuss and make

recommendations on transfusion-related

acute lung injury. In the afternoon, the

committee will hear presentations on

studies on leukoreduction filtration

failures.

Procedure: On June 14, 2001, from

8:30 a.m. to 5:30 p.m. and on June 15,

2001, from 8:30 a.m. to 3:45 p.m., the

meeting is open to the public. Interested

persons may present data, information,

or views, orally or in writing, on issues

pending before the committee. Written

submissions may be made to the contact

person by June 8, 2001. Oral

presentations from the public will be

scheduled between approximately 10:15

a.m. and 10:45 a.m., 2:30 p.m. and 3

p.m., and 4:45 p.m. and 5 p.m. on June

14, 2001; and between approximately

10:15 a.m. and 10:45 a.m., and 1:45 p.m.

and 2:15 p.m. on June 15, 2001. Time

allotted for each presentation may be

limited. Those desiring to make formal

oral presentations should notify the

contact person before June 8, 2001, and

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

requested to make their presentation.

Closed Committee Deliberations: On

June 15, 2001, from 3:15 p.m. to 3:45

p.m., the meeting will be closed to

permit discussion where disclosure

would constitute a clearly unwarranted

invasion of personal privacy (5 U.S.C.

552b(c)(6)). The committee will discuss

reports of the review of individual

research programs in the Division of

Hematology, Office of Blood Research

and Review, CBER.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: May 25, 2001.

Linda A. Suydam,

Senior Associate Commissioner.

[FR Doc. 01–14286 Filed 6–1–01; 4:12 pm]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel,

Epidemiologic Studies of the Mayak and

Techa River Cohorts.

Date: June 6, 2001.

Time: 1:00 p.m. to 3:00 p.m.

Agenda: To review and evaluate contract

proposals.

Place: National Cancer Institute, 6116

Executive Boulevard, Room 8105, Bethesda,

MD 20892, (Telephone Conference Call).

Contact Person: Lalita D. Palekar, PhD,

Scientific Review Administrator, Special

Review, Referral and Resources Branch,

Division of Extramural Activities, National

Cancer Institute, National Institutes of

Health, 6116 Executive Boulevard, Room

8105, Bethesda, MD 20892–7405, (301) 496–

7575.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: May 24, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14161 Filed 6–5–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute, Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Training

Grants.

Date: June 27, 2001.

Time: 6:00 PM to 7:30 PM.

Agenda: To review and evaluate grant

applications.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Ave., Chevy Chase, MD 20815.

Contact Person: Olivia Preble Bartlett, PhD,

Chief, Grants Review Branch, Grants Review

Branch, Division of Extramural Activities,

National Cancer Institute, National Institutes

of Health, 6116 Executive Boulevard, Room

8121, Rockville, MD 20892–7405, 301/594–

2501.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: May 30, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14162 Filed 6–5–01; 8:45 am]

BILLING CODE 4140–01–M